Outcomes of Vaso-occlusive Crisis in Pediatric Sickle Cell Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-18
SponsorAssiut University
About this trial
This study aims to assess the incidence and clinical outcomes of vaso-occlusive crises in pediatric patients with sickle cell disease. Data will be collected and analyzed to identify risk factors and related complications.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Children aged 1-18 years. Confirmed diagnosis of sickle cell anemia by hemoglobin electrophoresis or high-performance liquid chromatography .
Disqualifiers
Patients with other hemoglobinopathies (e.g., thalassemia). Patients with incomplete medical records. Children with coexisting chronic diseases that may confound pain crises .
Trial population
Pediatric patients (1-18 years) with confirmed Sickle Cell Disease. The study observes the incidence and outcomes of vaso-occlusive crises (VOCs). Both sexes are eligible. Healthy volunteers are not included.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
No intervention
Other interventionretrospective observational study. No intervention will be administered; data will be collected from existing medical records of pediatric sickle cell patients at Assiut University Hospital.
Treatment groups
25 Participants
are divided into 1 treatment groupGroup A: Sickle Cell pediatric patients1 intervention
Trial outcomes
Primary outcomes
1
Incidence of vaso-occlusive crisis in pediatric sickle cell patients
Frequency of vaso-occlusive crisis episodes will be identified through retrospective chart review of pediatric sickle cell patients.
Time frame
Retrospective review of medical records from 2019 to 2024Secondary outcomes
1
Complications associated with vaso-occlusive crisis (e.g., acute chest syndrome, stroke, infections)
Complications related to vaso-occlusive crisis will be identified and documented from patient records.
Time frame
Throughout the study period (2019-2024)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: